Antonio Cherubini Selected Research

Occupational Therapy (Therapy, Occupational)

11/2019	An interdisciplinary statement of scientific societies for the advancement of delirium care across Europe (EDA, EANS, EUGMS, COTEC, IPTOP/WCPT).
1/2018	Non-pharmacological interventions for the improvement of post-stroke activities of daily living and disability amongst older stroke survivors: A systematic review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonio Cherubini Research Topics

Disease

25	Dementia (Dementias) 01/2023 - 07/2005
16	Cognitive Dysfunction 01/2023 - 06/2004
15	Delirium 01/2024 - 10/2013
11	Chronic Disease (Chronic Diseases) 11/2023 - 06/2003
11	Frailty 04/2023 - 01/2003
9	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 09/2002
9	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 05/2002
8	Inflammation (Inflammations) 04/2024 - 02/2006
8	Heart Failure 11/2023 - 06/2003
8	Osteoporosis 09/2023 - 04/2003
7	Drug-Related Side Effects and Adverse Reactions 12/2023 - 11/2003
7	COVID-19 12/2023 - 12/2020
7	Sarcopenia 09/2023 - 10/2017
7	Ischemic Stroke 01/2012 - 03/2002
6	Neoplasms (Cancer) 11/2021 - 02/2004
6	Stroke (Strokes) 06/2019 - 01/2005
4	Osteoarthritis 09/2023 - 11/2019
4	Hypertension (High Blood Pressure) 01/2022 - 10/2002
4	Pressure Ulcer (Bedsore) 01/2019 - 01/2005
3	Musculoskeletal Diseases (Musculoskeletal Disease) 09/2023 - 11/2022
3	Malnutrition (Nutritional Deficiencies) 01/2022 - 07/2016
3	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2022 - 11/2007
3	Anemia 11/2021 - 06/2005
3	Urinary Incontinence 03/2020 - 01/2005
3	Cerebrovascular Disorders (Cerebrovascular Occlusion) 10/2019 - 01/2014
3	Hyperglycemia 03/2010 - 01/2006
2	Vitamin D Deficiency 11/2022 - 04/2007
2	Dyslipidemias (Dyslipidemia) 04/2022 - 06/2003
2	Deglutition Disorders (Dysphagia) 01/2022 - 01/2019
2	Lewy Body Disease (Lewy Body Dementia) 01/2022 - 01/2004
2	Insulin Resistance 01/2021 - 11/2010
2	Weight Loss (Weight Reduction) 01/2021 - 10/2007
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2016 - 01/2016
2	Renal Insufficiency (Renal Failure) 02/2013 - 03/2008
2	Azotemia 03/2010 - 11/2007
2	Liver Diseases (Liver Disease) 03/2010 - 11/2007
2	Hyponatremia 03/2010 - 11/2007
2	Pain (Aches) 01/2010 - 05/2008
2	Hyperparathyroidism 01/2009 - 11/2005
1	Pneumonia (Pneumonitis) 11/2023

Drug/Important Bio-Agent (IBA)

15	Biomarkers (Surrogate Marker)IBA 04/2024 - 10/2005
10	Antipsychotic Agents (Antipsychotics)IBA 08/2022 - 06/2004
9	AntioxidantsIBA 12/2015 - 03/2002
7	PolyphenolsIBA 11/2022 - 10/2011
6	Uric Acid (Urate)IBA 10/2019 - 04/2003
6	hydroxide ionIBA 01/2019 - 11/2005
5	Vitamin D FDA LinkGeneric 11/2022 - 04/2007
5	Cholinergic Antagonists (Anticholinergics)IBA 10/2021 - 01/2014
5	Vitamin E FDA LinkGeneric 03/2008 - 02/2004
4	Carotenoids (Carotene)IBA 08/2015 - 03/2002
4	beta Carotene (Betacarotene)FDA Link 02/2009 - 03/2002
3	Hemoglobins (Hemoglobin)IBA 11/2023 - 06/2005
3	C-Reactive ProteinIBA 04/2023 - 07/2014
3	Antidepressive Agents (Antidepressants)IBA 08/2022 - 11/2007
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 11/2010
3	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2022 - 11/2002
3	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2017 - 02/2006
3	CholesterolIBA 01/2017 - 03/2004
3	Vitamin A (Retinol)FDA LinkGeneric 08/2015 - 02/2004
3	Blood Glucose (Blood Sugar)IBA 03/2010 - 01/2006
3	alpha-Tocopherol FDA Link 02/2009 - 03/2006
3	Ascorbic Acid (Vitamin C)FDA LinkGeneric 03/2008 - 02/2004
3	Malondialdehyde (Propanedial)IBA 03/2008 - 03/2002
3	Protons (Proton)IBA 07/2006 - 10/2002
2	pro-brain natriuretic peptide (1-76)IBA 12/2023 - 01/2022
2	Apolipoproteins E (ApoE)IBA 01/2023 - 09/2002
2	ApolipoproteinsIBA 01/2023 - 09/2002
2	CreatinineIBA 01/2023 - 03/2008
2	oxidized low density lipoproteinIBA 01/2017 - 01/2013
2	ResveratrolIBA 12/2015 - 07/2014
2	Parathyroid Hormone (Parathormone)IBA 01/2014 - 01/2009
2	25-hydroxyvitamin DIBA 02/2012 - 07/2010
2	Hypnotics and Sedatives (Sedatives)IBA 03/2010 - 11/2007
2	ElectrolytesIBA 03/2010 - 11/2007
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2009 - 03/2008
2	Proteins (Proteins, Gene)FDA Link 03/2008 - 09/2006
2	LipidsIBA 02/2006 - 07/2005
2	Free RadicalsIBA 10/2005 - 05/2002
2	MicronutrientsIBA 01/2005 - 03/2002
2	CreatineIBA 02/2003 - 10/2002
1	Cell-Free Nucleic AcidsIBA 04/2024
1	16S Ribosomal RNAIBA 12/2023
1	Bacterial DNAIBA 12/2023
1	DNA (Deoxyribonucleic Acid)IBA 12/2023
1	Fatty Acid Binding Protein 3IBA 12/2023
1	Fatty Acid-Binding ProteinsIBA 12/2023

Therapy/Procedure

14	Polypharmacy 01/2023 - 01/2012
14	Activities of Daily Living (ADL) 09/2022 - 12/2007
10	Therapeutics 03/2020 - 02/2013
7	Home Nursing (Nursing, Home) 01/2022 - 10/2012
4	Long-Term Care 01/2024 - 01/2010
4	Drug Therapy (Chemotherapy) 12/2023 - 08/2011
4	Urinary Catheters 01/2021 - 07/2016
3	Patient Readmission 11/2023 - 02/2008
3	Length of Stay 01/2022 - 01/2005
3	Institutionalization (Institutionalized Persons) 02/2016 - 01/2003
2	Catheters 01/2020 - 07/2016
2	Drug Prescriptions 12/2019 - 12/2009
2	Occupational Therapy (Therapy, Occupational) 11/2019 - 01/2018
2	Bed Rest (Bedrest) 01/2019 - 12/2017